Dr. David Gordon Allan, MD

Dr. Allan practices at Lakeview Regional Medical Center in Covington, Louisiana.

Dr. Allan's NPI, 1104318682, was assigned on May 31, 2018. Dr. Allan graduated from The University of Queensland Medical School in 2017. Dr. Allan holds Florida license ME151350.

Dr. Allan's primary practice is Lakeview Regional Medical Center, at 95 Judge Tanner Blvd, Covington, LA 70433 in Saint Tammany Parish. The practice phone is (504) 503-4000.

Dr. Allan's primary practice is Lakeview Regional Medical Center in Covington, Louisiana. Dr. Allan is also affiliated with East Jefferson General Hospital. The medical group on file is Apogee Physicians. Dmand AI also links Dr. Allan to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Allan practices, 4 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Allan's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Allan is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Allan's licenses on file in 2 states: Florida and Louisiana.

Dmand AI lists bile duct problems, cardiac arrhythmia, chronic hypertension, circulation problems, circulatory problems in extremities, congestive heart failure, electrolyte disorders and fibromyalgia and chronic pain among the conditions Dr. Allan treats.

CMS data shows 958 Medicare services from Dr. Allan across 5 procedure codes in 2024, for 285 Medicare patients. Medicare paid $77,000 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 285 Medicare patients who saw Dr. Allan in 2024. The largest group is 75 to 84, with 117 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Allan's median patient age at 71, with 53% women.

In 2024, Dr. Allan wrote 889 Medicare Part D claims for 264 patients. 87% of them were for generic drugs. CMS names the drug for 651 of them, across 23 drugs with 11 or more claims each, at $46,587 in total drug cost. In 2023, CMS named 337 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Allan for performance year 2024, reported as part of a group. Dr. Allan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 8 general payments to Dr. Allan from 6 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $125.

Dr. Allan graduated from The University of Queensland Medical School in 2017.

Dr. Allan is in network with 4 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross and Blue Shield of Louisiana. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.